· Weekly signal · GH
Guardant Health Inc (GH) reaches 113.7% 12-week gain with active trend
The precision-oncology diagnostics stock enters July with strong multiweek gains, though participation readings are not fully aligned.
Guardant Health Inc (GH) closed the week ended July 3 at $167.98 after gaining 12.6%, extending its four-week advance to 33.7%. The chart is a weekly price path over 52 weeks, framing the move as longer-horizon context rather than live intraday trading.
Confirmation remains constructive, with the trend state active, Relative Strength at 63.4 and Market Dynamics at 1.21. The complication is volume: latest weekly turnover was above its 13-week average, while the active-mover screen showed a lighter 0.6x reading.